|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/7056 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| A61P 31/22 | (2006.01) |
| (11) | Number of the document | 4433065 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22826859.5 |
| Date of filing the European patent application | 2022-11-18 | |
| (97) | Date of publication of the European application | 2024-09-25 |
| (45) | Date of publication and mention of the grant of the patent | 2026-03-11 |
| (46) | Date of publication of the claims translation | 2026-04-27 |
| (86) | Number | PCT/US2022/050341 |
| Date | 2022-11-18 |
| (87) | Number | WO 2023/091625 |
| Date | 2023-05-25 |
| (30) | Number | Date | Country code |
| 202163281206 P | 2021-11-19 | US |
| (72) |
SONG, Heng , US
SUN, Kefeng , US
CROUTHAMEL, Matthew , US
CHEN, Grace , US
ZHU, Andy Z.X. , US
MICHON, Ingrid Nicolle , US
BURT, Howard James , US
BARTER, Zoe Elizabeth , US
NEUHOFF, Sibylle , US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome
Chuo-ku, Osaka-shi, Osaka 541-0045,
JP
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Maribaviro naudojimas citomegaloviruso infekcijos gydymui ir jo gydymo režimai |
| USE OF MARIBAVIR FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTION AND TREATMENT REGIMENS THEREOF |